Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
17.29
-0.70 (-3.90%)
Nov 4, 2024, 1:04 PM EST - Market open
Myriad Genetics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$28.18
Upside
+62.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Initiates $32 | Hold | Initiates | $32 | +85.08% | Sep 19, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $35 | Buy | Initiates | $35 | +102.43% | Aug 27, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $29 → $34 | Buy | Maintains | $29 → $34 | +96.65% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | +73.51% | Aug 13, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | +73.51% | Aug 7, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $17 → $20 | Sell | Maintains | $17 → $20 | +15.67% | Aug 7, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $29 | Buy | Initiates | $29 | +67.73% | Jun 27, 2024 |
| Jefferies | Jefferies | Hold → Sell Initiates $25 → $20 | Hold → Sell | Initiates | $25 → $20 | +15.67% | Jun 3, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $23 → $28 | Hold | Maintains | $23 → $28 | +61.94% | May 13, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $25 → $35 | Hold → Buy | Upgrades | $25 → $35 | +102.43% | May 8, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $31 | Strong Buy | Maintains | $28 → $31 | +79.29% | Jan 30, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $31 | Strong Buy | Maintains | $28 → $31 | +79.29% | Jan 29, 2024 |
| Piper Sandler | Piper Sandler | Hold Initiates $23 | Hold | Initiates | $23 | +33.02% | Dec 21, 2023 |
| Wells Fargo | Wells Fargo | Hold Initiates $20 | Hold | Initiates | $20 | +15.67% | Dec 19, 2023 |
| Guggenheim | Guggenheim | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +33.02% | Dec 14, 2023 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 13, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.